Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Arca

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
Drugs|December 6, 2007
Atorvastatin: a safety and tolerability profileMarcello Arca
Atherosclerosis. Supplements|February 10, 2015
Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndromeMarcello Arca
Atherosclerosis|December 21, 2016
Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitorsMarcello Arca
Drugs|December 6, 2007
Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndromeMarcello Arca
Recenti Progressi in Medicina|October 9, 2019
[PCSK9 inhibitors (PCSK9i), a new opportunity for cardiovascular prevention: clinical and regulatory aspects and access to therapy.]Marcello Arca
Drugs|December 6, 2007
Atorvastatin efficacy in the primary and secondary prevention of cardiovascular eventsMarcello Arca, Achille Gaspardone
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 18, 2014
In Memoriam. Obituary: Professor Andrea Mezzetti, MD (1949-2013)Marcello Arca, Renato Fellin
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 23, 2011
Treating statin-intolerant patientsMarcello Arca, Giovanni Pigna
Drugs|December 6, 2007
Atorvastatin: its clinical role in cerebrovascular preventionAchille Gaspardone, Marcello Arca
Current Vascular Pharmacology|December 25, 2012
Mechanisms of diabetic dyslipidemia: relevance for atherogenesisMarcello Arca, Giovanni Pigna, Carla Favoccia
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Drugs|December 6, 2007
Atorvastatin: a safety and tolerability profileMarcello Arca
Atherosclerosis. Supplements|February 10, 2015
Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndromeMarcello Arca
Atherosclerosis|December 21, 2016
Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitorsMarcello Arca
Drugs|December 6, 2007
Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndromeMarcello Arca
Recenti Progressi in Medicina|October 9, 2019
[PCSK9 inhibitors (PCSK9i), a new opportunity for cardiovascular prevention: clinical and regulatory aspects and access to therapy.]Marcello Arca
Drugs|December 6, 2007
Atorvastatin efficacy in the primary and secondary prevention of cardiovascular eventsMarcello Arca, Achille Gaspardone
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 18, 2014
In Memoriam. Obituary: Professor Andrea Mezzetti, MD (1949-2013)Marcello Arca, Renato Fellin
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 23, 2011
Treating statin-intolerant patientsMarcello Arca, Giovanni Pigna
Drugs|December 6, 2007
Atorvastatin: its clinical role in cerebrovascular preventionAchille Gaspardone, Marcello Arca
Current Vascular Pharmacology|December 25, 2012
Mechanisms of diabetic dyslipidemia: relevance for atherogenesisMarcello Arca, Giovanni Pigna, Carla Favoccia
Pageof 22